Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	43.24B -14.2%
Revenue (ttm)	18.09B +0.7%
Net Income	1.35B -16.9%
EPS	0.99 -16.8%
Shares Out	1.37B
PE Ratio	31.92
Forward PE	24.83
Dividend	1.00 (3.18%)
Ex-Dividend Date	n/a

Volume	24,158,550
Average Volume	14,294,173
Open	32.00
Previous Close	31.46
Day's Range	31.53 - 32.49
52-Week Range	29.75 - 38.36
Beta	0.17
RSI	53.47
Earnings Date	Mar 31, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.